908 Devices Q4 revenue $17.2M (+20% YoY); FY2025 ~$56M (+17%), positive Adj. EBITDA in Q4

908 Devices Inc.

2025-FY EPS reported $0.54 revenue$56,197,000

Q4 2025 revenue ~$17.2M versus $14.3M in Q4 2024, growth of ~20%.
FY2025 revenue ~$56.0M, up ~17% from $47.7M in FY2024, at high end of guidance.
Achieved positive Adjusted EBITDA in the fourth quarter, meeting a key goal.
Strength from U.S. state/local channel, ramping VipIR international sales, and federal/defense customers.
CEO cites macro tailwinds: increased fentanyl/opioid crisis funding and rising global defense budgets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.